Medtronic CRT Devices Now Approved To Treat Patients With AV Block And Reduced Heart Function

Medtronic, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D).
Source: Medical Design Online News - Category: Medical Equipment Source Type: news